Insider Transactions in Q4 2022 at Silk Road Medical Inc (SILK)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 15
2022
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+7.26%
|
$15,000
$1.6 P/Share
|
Dec 13
2022
|
Tony M. Chou |
SELL
Open market or private sale
|
Direct |
10,060
-10.18%
|
$553,300
$55.0 P/Share
|
Dec 13
2022
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
25,000
-12.41%
|
$1,375,000
$55.0 P/Share
|
Dec 13
2022
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+11.04%
|
$25,000
$1.6 P/Share
|
Dec 12
2022
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-3.9%
|
$530,000
$53.85 P/Share
|
Dec 12
2022
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.76%
|
$10,000
$1.6 P/Share
|
Dec 01
2022
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,753
-3.32%
|
$357,909
$53.0 P/Share
|
Dec 01
2022
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,753
+3.2%
|
$6,753
$1.53 P/Share
|
Nov 11
2022
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
24,800
-12.32%
|
$1,240,000
$50.0 P/Share
|
Nov 11
2022
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,800
+10.97%
|
$24,800
$1.6 P/Share
|
Nov 11
2022
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-3.9%
|
$500,000
$50.03 P/Share
|
Nov 11
2022
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.76%
|
$10,000
$1.6 P/Share
|
Nov 09
2022
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
200
-0.11%
|
$10,000
$50.0 P/Share
|
Nov 09
2022
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+0.11%
|
$200
$1.6 P/Share
|
Nov 01
2022
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,753
-6.43%
|
$297,132
$44.17 P/Share
|
Nov 01
2022
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,753
+6.05%
|
$6,753
$1.46 P/Share
|
Oct 11
2022
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-3.9%
|
$420,000
$42.32 P/Share
|
Oct 11
2022
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.76%
|
$10,000
$1.6 P/Share
|
Oct 04
2022
|
Lucas W. Buchanan COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,592
-1.45%
|
$121,824
$47.86 P/Share
|
Oct 03
2022
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,753
-6.43%
|
$297,132
$44.76 P/Share
|
Oct 03
2022
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,753
+6.05%
|
$6,753
$1.46 P/Share
|